Hi [[ session.user.profile.firstName ]]

ICON Webinars

  • Date
  • Rating
  • Views
  • Industry Perceptions and Expectations - The Role of ICER as an Independent HTA
    Industry Perceptions and Expectations - The Role of ICER as an Independent HTA
    Mike Pace, Sr. Principal, Global Pricing & Market Access; Nathan White, Senior Vice President, Integrated Access & Outcomes Recorded: Nov 28 2018 63 mins
    This webinar explores:

    - The evolution of health technology assessment in the US and possibilities for the future
    - Opinions of manufacturers and US payer stakeholders on the role of - - ICER in the US healthcare system, as learned through a primary research study of more than 50 participants
    ICER methodologies and approaches to evaluation of clinical and health economic evidence
    - Ways manufacturers can begin to more proactively prepare for an ICER assessment
  • The Template for a Successful Digital Trial
    The Template for a Successful Digital Trial
    Marie McCarthy, Sr. Director, Product Innovation; Chen Admati, Director, Intel Pharma Analytics Recorded: Nov 8 2018 61 mins
    Despite the increasing availability of mHealth technologies that can successfully capture physiological data, and digital platforms that can ingest and analyze the data to date, the adoption of these technologies is only cautiously embraced in clinical research.

    This webinar discuss the main challenges in the areas of:

    - Patient Engagement and Burden
    - Device Suitability
    - Data Complexity and Insight Generation
    - Operationalization
    - Privacy and Security Issues
    - Regulatory Acceptance
  • Applying the latest Digital Trends to Patient, Provider and Payer Communications
    Applying the latest Digital Trends to Patient, Provider and Payer Communications
    Marissa DiCindio, Digital marketing Manager, ACC,ICON; Marie McCarthy, Sr. Director Product Innovation, ICON Recorded: Oct 26 2018 52 mins
    If you are curious about the latest digital trends and how that innovation is being implemented into real world communication needs, don't miss this webinar.

    We review current trends and how digital technology and innovation are being applied to patient, healthcare professional, payer, and other decision maker communications.

    With a world population of 7.6 billion people using over 21 billion internet connected devices, digital interactions are not only fundamental, they require continued evolution to maintain appropriate reach and responsiveness.

    You’ll gain insights from our collection of case studies, and learn how companies are applying the latest digital trends in Artificial Intelligence (AI), including voice enablement and chatbots, wearables, point of care electronic health record messaging, social media, transportation, do-it-yourself healthcare, and more.
  • Overcoming New EU MDR & IVDR Regulation Challenges
    Overcoming New EU MDR & IVDR Regulation Challenges
    Karen Hill, Sr. Manager, Reg Affairs, Medical Devices, ICON Recorded: Sep 17 2018 50 mins
    The new European Medical Devices Regulation (MDR) and the In Vitro Diagnostic Medical Devices Regulation (IVDR) represent some of the most wide-ranging and disruptive changes to recently affect the world’s second-largest medical technology market. Now, with just a two- to four-year transition period before full compliance is required in 2020 for MDR and 2022 for IVDR, device developers will need to implement changes to help new and existing products succeed.

    This webinar discusses:

    - The key changes that are occurring under the new regulations
    - How to prioritize your product portfolio
    - The importance of early planning in preparing clinical studies to certify new devices and to recertify existing ones
    - How early transition can give your products an advantage in the market
  • Risk Based Monitoring: The Site Perspective
    Risk Based Monitoring: The Site Perspective
    Emer Doherty, Director, Project Management, ICON; Nycole Rameriz, Director Clinical Management, ICON Recorded: Sep 13 2018 57 mins
    Risk based monitoring has been emerging for years. The 2017 release of ICH E6 R2 introduced the world of technology to a 20-year-old guideline with increased focus on delivering quality and efficiencies in clinical trials. This webinar explores the evolution of centralised, risk based monitoring, specifically addressing the impact on sites, examining the growing pains, and fostering dialogue and awareness between CROs, sponsors and sites.

    Topics covered include:

    - Advancing our quest for quality management to continually improve the way we monitor clinical trials by placing emphasis on what really matters
    - Focusing on data and processes that are critical to patient safety and data integrity, putting the patient first
    - Leveraging technologies that enhance a quality-driven perspective and discussing what all of this means for the industry
  • How Real World Evidence Continues to Shape the Late Phase Landscape
    How Real World Evidence Continues to Shape the Late Phase Landscape
    Bill Row, Divisional Principal, RWE; Bruce Capobianco, Sr, Director, RWE Technology; Holly Watts, Project Director Recorded: Jul 30 2018 59 mins
    - Real World Evidence Dynamics and Alignment with Late Phase Research
    - Developing an RWE Strategy
    - Connecting TEchnology to an RWE Strategy
  • The Obsessive Compulsive Drinking Scale (OCDS) - A Mapi Webinar
    The Obsessive Compulsive Drinking Scale (OCDS) - A Mapi Webinar
    Raymond F. Anton; Peiro Bindi Recorded: Jul 30 2018 59 mins
    A short questionaire to assess alcohol use.
  • NASH Clinical Trials - Challenges and Considerations
    NASH Clinical Trials - Challenges and Considerations
    Dr. Andrew Roche, PhD, Scientific Director, Global Validation, Scientific Affairs, ICON Recorded: Jul 30 2018 47 mins
    Overview of current challenges associated with NASH Clinical Trials and examination of potential strategies to address during trial design or study execution.
  • Imapct of FDA's Recent Guidance on Payer Communications
    Imapct of FDA's Recent Guidance on Payer Communications
    Nathan White, Sr. VP Integrated Access & Outcomes Solutions; Sean P. Wagner, Sr. VP, Strategic & Client Services, ICON Recorded: Jul 23 2018 58 mins
    Our experts explore how manufacturers can successfully implement this guidance and integrate new communication channels with payers. This webinar will cover:

    - The history of FDAMA section 114 and rationale for amendment legislation
    - Differences between the draft and final FDA guidance
    - Industry and public concerns and questions
    - “CFL guidance” related to consistency of labelling in medical communications
    - Challenges with the promotional versus scientific exchange debate
    - Key opportunities and considerations for industry
  • Measuring Pregnancy and Labour Pain Using Clinical Outcome Assessments
    Measuring Pregnancy and Labour Pain Using Clinical Outcome Assessments
    Pamela J. Angle, University of Toronto and Marie Dulac Trimoreau, Mapi Research Trust Recorded: Jun 13 2018 49 mins
    This is a Mapi Research Trust recorded webinar. Presented by Pamela J. Angle, University of Toronto and Marie Dulac Trimoreau, Mapi Research Trust

Embed in website or blog